On ECHEMI
Home > Drugs > Xinjiang Huashidan Pharmaceutical Co., Ltd.
Xinjiang Huashidan Pharmaceutical Co., Ltd.
  • Founded in:

    1998-12-08
  • Country:

    China China
  • Address:

    No. 169, Henan East Road, High-tech Zone (New City District), Urumqi, Xinjiang
  • Tax NO.:

    91650100710886758T
  • Registered Funds:

    26.4552 million yuan
  • Website:

  • Email:

Related Drugs
Inosine Glucose Injection
Chemical name: 9β-D-ribosyl hypoxanthine, molecular formula: C10H12N4O5
Name Description Content CAS NO. Registered Holders
Inosine

Inosine is a normal component of the human body. It participates in nucleic acid metabolism, protein synthesis and energy metabolism in the body. It can increase the activity of coenzyme A and pyruvate oxidase, thereby allowing cells to metabolize normally under hypoxia. Inosine helps to restore the function of damaged liver cells.

More

Inosine is a normal component of the human body. It participates in nucleic acid metabolism, protein synthesis and energy metabolism in the body. It can increase the activity of coenzyme A and pyruvate oxidase, thereby allowing cells to metabolize normally under hypoxia. Inosine helps to restore the function of damaged liver cells.

58-63-9 8
Troxerutin and Glucose Injection
Name Description Content CAS NO. Registered Holders
Troxerutin

7085-55-4 25
GLUCOSE

58367-01-4 15
Donkey-hide gelatin bone strengthening oral liquid
Donkey-hide gelatin.
Name Description Content CAS NO. Registered Holders
donkey-hide gelatin

Not yet clear

More

Not yet clear

0
Clindamycin Phosphate and Glucose Injection
The main ingredient of this product is clindamycin phosphate. Its chemical name is 6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-7-(S)-chloro-6,7,8-trideoxy.
Name Description Content CAS NO. Registered Holders
Clindamycin phosphate

It inhibits bacterial protein synthesis and has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Staphylococcus epidermidis, hemolytic Streptococcus, viridans Streptococcus, Pneumococcus, Corynebacterium diphtheriae, as well as anaerobic bacteria such as Peptococcus, Peptostreptococcus, Bacteroides fragilis, Fusobacterium, Eubacterium, and Propionibacterium. Enterococci are resistant to it.

More

It inhibits bacterial protein synthesis and has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Staphylococcus epidermidis, hemolytic Streptococcus, viridans Streptococcus, Pneumococcus, Corynebacterium diphtheriae, as well as anaerobic bacteria such as Peptococcus, Peptostreptococcus, Bacteroides fragilis, Fusobacterium, Eubacterium, and Propionibacterium. Enterococci are resistant to it.

24729-96-2 33
Clindamycin Phosphate and Glucose Injection
The main ingredient of this product is clindamycin phosphate. Its chemical name is 6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-7-(S)-chloro-6,7,8-trideoxy.
Name Description Content CAS NO. Registered Holders
Clindamycin phosphate

It inhibits bacterial protein synthesis and has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Staphylococcus epidermidis, hemolytic Streptococcus, viridans Streptococcus, Pneumococcus, Corynebacterium diphtheriae, as well as anaerobic bacteria such as Peptococcus, Peptostreptococcus, Bacteroides fragilis, Fusobacterium, Eubacterium, and Propionibacterium. Enterococci are resistant to this product.

More

It inhibits bacterial protein synthesis and has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Staphylococcus epidermidis, hemolytic Streptococcus, viridans Streptococcus, Pneumococcus, Corynebacterium diphtheriae, as well as anaerobic bacteria such as Peptococcus, Peptostreptococcus, Bacteroides fragilis, Fusobacterium, Eubacterium, and Propionibacterium. Enterococci are resistant to this product.

24729-96-2 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.